GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders +12.5% ·
aandelenstroom -10.9% ·
netto nieuwe posities +11.1%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passief) | 2.85M | — | $87.04M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 2.82M | 0.0% | $86.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 2.82M | 0.0% | $86.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.89M | +38.5% | $57.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.48M | +348.5% | $45.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.48M | +348.5% | $45.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | ARK Investment Management ✦ | 1.44M | -4.8% | $43.99M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 1.23M | +87.6% | $37.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Norges Bank ✦ (passief) | 1.19M | +1.1% | $36.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 873.08K | Nieuw | $26.67M | 0.1% | New | 1 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 503.10K | +14.8% | $15.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 279.80K | +392.6% | $8.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 96.40K | -88.6% | $2.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | PRIMECAP Management ✦ | 43.69K | -34.0% | $1.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 32.09K | Nieuw | $980,197 | 0.0% | New | 1 | SEC ↗ |
| 27 | Bridgewater Associates ✦ | 12.54K | -30.9% | $383,219 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Gotham Asset Management ✦ | 7.82K | -48.5% | $238,932 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $26.67M | 0.1% |
| Marshall Wace | $980,197 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 481 houders, 137.05M aandelen, $11.53B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 20.89K aand · $3.53M
Officer, Director · 7.59K aand · $1.29M
Officer, Director · 9.02K aand · $1.52M
Director · 116 aand · $18,148
Officer · 13.25K aand · $2.20M
Officer · 3.70K aand · $605,286
Officer · 9.93K aand · $1.63M
Officer · 19.01K aand · $3.14M
Officer · 400 aand · $67,168
Officer · 3.46K aand · $579,639
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie